Urinary Incontinence Market by type (urge incontinence, overflow incontinence, stress incontinence, functional incontinence, and mixed urinary incontinence), by end-user (ambulatory surgical centres, clinics, hospitals, home use, and others), by Devices (electrical stimulation, urethral bulking agents, urinary catheters, and neuromodulation devices) and Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America), Global Forecast 2019 to 2029

The rising advancement in technologically advanced urinary incontinence devices have promoted the Urinary Incontinence Market across the globe

Covid-19 Analysis and Impact Assessment

The covid-19 outbreak has affected the market of urinary incontinence as many patients with multiple dialyses were not able to access the healthcare facility during the world-wide lockdown. However, the situation is improving steadily with all the recent innovations and developments among the key players in the urinary incontinence market. But still, many people from rural areas are not able to access healthcare facilities.

The global Urinary Incontinence market size is expected to reach close to USD 8.7 billion by 2029 with an annualized growth rate of 5.39% through the projected period.

The Stress Incontinence Segment is Projected to Hold the Largest Market Share

The stress urinary incontinence has a significant impact on the life among the people most on women, according to reports stress incontinence affects 15% of older women across the globe and about 75% of women have painful symptoms. With the increasing level of advancement in the treatment for stress incontinence over the recent years has increased the market growth. The stress incontinence treatment includes therapies and surgeries, the advanced surgical devices and techniques have opened path for various procedures for stress incontinence.

The Neuromodulator Device is Expected to be the Most Lucrative Segment

Neuromodulator device are used as an effective therapy for patients with abnormal bladder. The raising number of trial for neuromodulator to establish the safety and  the efficient use of the device have brought awareness among the patients. Sacral neuromodulator are used to treat lower urinary incontinence symptoms, it can control bladder dysfunction for people with urge incontinence who have not responded to the medication or drugs. Neuromodulator are also used for treating stress incontinence and proven highly effective with 90% cure and improvement rates.

Based on End-Use Hospital Segment is Likely to Emerge

The hospitals segment is expected to remain the most remunerative segments in the forecast era. The increasing availability of advance technology for treatment of urinary incontinence have a greater impact on the hospitality industries, the innovation and adopting of various surgical therapies and mediation have brought a great awareness among the people about urinary incontinence. And in addition to it the availability of skilled professionals and advanced healthcare facilities plays a major role in the hospital, indeed which is also a major factor for the growth of hospital segment in urinary incontinence market.

North America to Experience Massive Growth Waves in the Forecast Era

Owing to advances in urinary inconsistence device development and the presence of major market veternas in the region, also backed by rising patient pools, the region of North America is expected to remain the fastest-growing region in the forthcoming years. The raising urinary incontinence in this region has brought many developments in the healthcare centers, which makes the availability range for treatment more.

Asia Pacific is also about to boost the market revenue in the forecast period. The increasing prevalence of urinary incontinence among women in this region is high, due to the lack of healthcare services and but the growing awareness among the people have witnessed the various treatment available to treat urinary incontinence.

The favorable policies and patient preferences for the treatment of urinary incontinence, are likely to bolster growth in the global urinary incontinence market in the forecast era

Urinary incontinence (UI) is the abnormal urine loss, loss of bladder control, slight loss of urine after sneezing or coughing, complete inability to control urination. Urinary incontinence is quite a common occurrence across patient pools and is experienced most by elderly women. The treatment for urinary incontinence depends upon the type, age, the general and mental health of the patients. Mediation for urinary incontinence is usually used in combination with techniques and exercises.

The World Health Organization has recognized urinary incontinence as a priority health issue as it is faced by a large population, and this distressing medical condition may significantly lower people’s quality of life. Urinary incontinence impact has been more on the elderly population, it has a significantly negative impact on physical health, psychological functions due to the social isolation, disturbance in sleep, and less satisfaction in life. Growing awareness and large scale prevalence of urinary incontinence are expected to open up new growth opportunities in terms of technological advancement and global acceptance of novel devices.

In addition, the common factors linked with urinary incontinence are increasing age, obesity, diabetics, pelvic pain, vaginal deliveries, and respiratory problem. These factors may result into urological or non-urological conditions. Urological condition is abnormal functioning of bladder or urethral whereas, non-urological conditions are severe infections, restricted mobility, polyuria, drugs and mediation.

There are several forms of urinary inconsistence and the most common ones are identified as mixed, stressed, and urge urinary inconsistence. UI among the younger generation is mainly due to the lower tract symptoms, but in elderly generation patients UI is classified as geriatric syndrome.

Over the recent years, urinary incontinence is the most common condition among the people, due to significant increase in medical and economic issues and increase rate in chronic diseases like diabetics and dementia are the factors that drives the growth of the market in the forecast period.

The developing standardised criteria and treatment strategies in management and containment of UI in older people with diabetics and dementia has reduced the burden on the caretakers of the patients. And also, the raising awareness, advancement in the devices, and professional UI therapies are the major growth factor in the market

Urinary incontinence is often not reported due to the lack of symptoms, knowledge, and less awareness about the treatment options available are the factors that shows negative impact on the market. UI is normal factor in the part of aging or consequences after the childbirth, most of the women delay the treatment which impacts the implementation of effective mediation and therapies.

Furthermore, patients take a long time before taking professional advice, this may be due to lack of awareness, hospitality facility near them, increased cost for the treatment. These are the potential factors that restricts the market growth at the certain point in the forecast period.

This report offers a detailed information and quality insight with market intelligence. This report is structured in a way that it offers maximum business value and information and provides critical market dynamics and will enable in the process of decision making for the current market players and those who are willing to enter the market. This report studies the forecast period of 10 years.

Proceeding ahead, this report contains information regarding the major key players, the competitive areas and strategies used by the leading companies in the market of urinary incontinence and the growth trends in the forthcoming years are discussed. In addition to it the impact of COVID—19 is discussed with industry’s initial response and tactics used by the companies to overcome the impact

Promedon, NeoTract, Inc., Cook Medical Inc., Coloplast Corp, C.R. Bard Inc., Boston Scientific Corporation, and Ethicon US, LLC, are some of the major players operating in the urinary incontinence market.

Latest Innovations: Global Urinary Inconsistence Market

• Medicare on June 2021, announced the insurance coverage for women incontinence treatment at home. This is likely to further improve home-based care and encourage large scale adoption across aging population.

Urinary Incontinence Market Scope

Key Segments of the Global Urinary Incontinence Market

Type Overview, (USD Billion)

• Urge incontinence
• Stress incontinence
• Overflow incontinence
• Functional incontinence
• Mixed incontinence

Devices Overview, (USD Billion)

• Electrical stimulation
• Urethral bulking agents
• Urinary catheters
• Neuromodulation devices
• Others

End-User Overview, (USD Billion)

• Hospitals
• Clinics
• Ambulatory surgical centres
• Home use
• Others

Regional Overview, (USD Billion)

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• Rest of Asia Pacific

South America

• Mexico
• Brazil
• Rest of South America

Middle East and South Africa